GlassScriptPhysician profile
Kanwar Y Singh
NPI 1679807093
$13,552.21
in general payments reported to CMS, 2019-2025
19 companies · $2,818 in 2025
The $2,818 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $547 · 2021: $500 · 2022: $846 · 2023: $6,145 · 2024: $2,153 · 2025: $2,818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,251 · Food and Beverage: $2,321 · Travel and Lodging: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,251.00 |
| Food and Beverage | $2,321.00 |
| Travel and Lodging | $543.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,836.16 | 2021-2025 | Micra, Linq II, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $1,243.64 | 2019-2025 | Ensite, Tacticath Ablation Catheter, Sensor Enabled, Thoratec Heartmate 3 Lvas Implant Kit |
| Atricure, INC. | $193.86 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $184.97 | 2023-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $135.17 | 2023 | Farxiga, Andexxa |
| Abiomed | $134.86 | 2019-2020 | |
| Amgen INC. | $120.54 | 2021-2022 | |
| Medtronic Vascular, INC. | $105.24 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $91.34 | 2020-2023 | Lifevest |
| Pfizer INC. | $89.90 | 2019-2024 | |
| Cardiva Medical, INC. | $87.80 | 2022-2024 | Ensoetm |
| Janssen Pharmaceuticals, INC | $86.92 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.43 | 2022-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $56.59 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $35.61 | 2023-2025 | Camzyos |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $21.03 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $20.67 | 2023 | Inpefa |
| Horizon Therapeutics Plc | $16.51 | 2021 | |
| Terumo Medical Corporation | $14.97 | 2025 | Tubing Kit - Stroke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kanwar Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.